Vault-13

CANTOR FITZGERALD & CO.

NEW YORK, NY · CIK 17018 · 13F filing filed 2025-08-14

As an employer

US visa salary filings

Job titleFilingsMedianRange
Analyst, Investment BankingNew York, NY 5 $105,000 $100,000 – $135,000
Analyst, Technology Investment BankingNew York, NY 3 $100,000 $100,000 – $110,000
Director, Senior Biotech AnalystNew York, NY 1 $275,000
Associate, HealthcareNew York, NY 1 $175,000
Investment Banking AnalystNew York, NY 1 $110,000
Analyst, FinanceNew York, NY 1 $105,000
Analyst, SalesNew York, NY 1 $100,000
Analyst, PowerNew York, NY 1 $100,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Cantor Fitzgerald & Co, Cantor Fitzgerald & Co..

For Q2 2025 this manager filed a 13F notice: its holdings were reported by another manager.

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
M3BRIGADE ACQUISITION V CORP VLOS · 13D · filed 2026-03-02 VLOS 27.1%≈ $84.3m no change 13D 2026-03-02
SONO GROUP N V SEV1USD · 13G · filed 2026-02-13 SEV1USD 7.0% new 13G 2026-02-13
ONKURE THERAPEUTICS INC OKUR · 13G · filed 2025-08-14 OKUR 5.2%≈ $3.1m new 13G 2025-08-14